OKYO
OKYO Pharma
OKYO
OKYO
7 hedge funds and large institutions have $1.18M invested in OKYO Pharma in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$19K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$6.73K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.84K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $1.11M | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $23.8K | +$6.73K | +5,853 | +39% |
|
|
3
Renaissance Technologies
New York
| $19K | +$19K | +16,500 | New |
|
4
Cerity Partners
New York
| $14.7K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $13.9K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $3.45K | +$2.84K | +2,473 | +471% |
|
|
CA
7
Continuum Advisory
Eagle,
Idaho
| $58 | – | – | – |
|